drugset / Trial / NCT05453253
Immune Response to a Delayed Second Dose of Oral Cholera Vaccine
Phase 4
Unknown
456 enrolled
Epicentre
Massachusetts General Hospital · collabMinistry of Health, Guinea · collabMédecins Sans Frontières, Belgium · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
Immune response to a delayed second dose of oral cholera vaccine A randomized, controlled, non-inferiority immunogenicity trial in Conakry, The Republic of Guinea
Timeline
- Start
- 2022-07-20
- Primary completion
- 2024-02-01
- Completion
- 2024-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Euvichol-Plus | Vaccine | — | Oral |